The Lancet

The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: a systematic review and meta-analysis

There was some evidence that cannabinoids can reduce symptoms of cannabis use disorder, insomnia, tic or Tourette's syndrome, and autism spectrum disorder, but the quality of this evidence was ...
PsyPost

The extreme male brain theory of autism applies more strongly to females

A comprehensive new study suggests that females require a much larger biological and cognitive shift to develop autism than males do. The findings help explain why the condition is diagnosed ...
Devdiscourse

Can AI improve financial literacy? Examining the promise and limits

Financial education is a key factor in promoting economic stability and responsible financial behavior. Individuals who understand financial concepts such as interest rates, risk diversification, ...

West Red Lake Gold Further De-Risks Fork Satellite Deposit with Successful Infill Drilling

VANCOUVER, British Columbia, March 17th, 2026, FinanceWireWest Red Lake Gold Mines Ltd.(“West Red Lake Gold” or “WRLG” or ...
MedPage Today on MSN

Cannabinoids for Mental, Substance Use Disorders 'Rarely Justified,' Study Suggests

Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...

Why Most Retail Traders Plateau—And What Finally Breaks The Cycle

Over the past decade, working closely with traders at different stages of development, I’ve observed a pattern that has little to do with indicators, platforms or asset classes. Most retail traders ...
PsyPost

Regular exercise reduces anxiety and depression in people with chronic insomnia

A new review of multiple studies suggests that regular physical activity can significantly lower anxiety and depressed moods ...
TMCnet

SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Conducting Sham Clinical ...

Levi & Korsinsky, LLP reminds purchasers of Soleno Therapeutics, Inc. (NASDAQ: SLNO) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors ...

SLNO Lawsuit Alleges Allegedly Conducting Sham Clinical Trials - Soleno Therapeutics, Inc. Investors Face Losses Following Allegedly Conducting Sham Clinical Trials: SueWallSt

NEW YORK, March 12, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Soleno Therapeutics, Inc. (NASDAQ: SLNO) securities of a pending securities class action. THE CASE: A class action ...

Instead of needling India, here’s why USCIRF should designate United States as a ‘country of particular concern’

Born of Christian evangelical advocacy, staffed by Islamists and chaired by a Christian culture-war activist, institutionally ...
BMJ Open

Effects of acceptance and commitment therapy for family caregivers of persons with dementia: a systematic review and meta-analysis protocol

Introduction With the rapid ageing of the global population, the number of persons with dementia (PwDs) is increasing, placing substantial psychological and physical burdens on family caregivers.
Devdiscourse

AI in audit workflow brings big gains and big challenges

Opportunities, Architecture, and Challenges: A Systematic Review,” published in Account Audit, the authors argue that AI is expanding audit coverage and improving anomaly detection, while also ...